前往化源商城

4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶

更新时间:2025-08-25 18:25:43

4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶结构式
4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶结构式
委托求购
常用名 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶 英文名 1H-Pyrazolo[3,4-d]pyrimidine,4-(methylthio)
CAS号 5418-10-0 分子量 166.20400
密度 1.47g/cm3 沸点 382.7ºC at 760mmHg
分子式 C6H6N4S 熔点 N/A
MSDS N/A 闪点 185.3ºC

 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶名称

中文名 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶
英文名 4-methylsulfanyl-1H-pyrazolo[3,4-d]pyrimidine

 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶物理化学性质

密度 1.47g/cm3
沸点 382.7ºC at 760mmHg
分子式 C6H6N4S
分子量 166.20400
闪点 185.3ºC
精确质量 166.03100
PSA 79.76000
LogP 1.07480
InChIKey BLEJJILOVWBLBZ-UHFFFAOYSA-N
SMILES CSc1ncnc2[nH]ncc12
折射率 1.713

 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶安全信息

海关编码 2933990090

 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶合成线路

~96%

4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶结构式

4-(甲基硫代)-1H-吡唑并...

5418-10-0

文献:TANABE SEIYAKU CO., LTD. Patent: EP1772454 A1, 2007 ; Location in patent: Page/Page column 61 ; EP 1772454 A1

~85%

4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶结构式

4-(甲基硫代)-1H-吡唑并...

5418-10-0

文献:Amersham Pharmacia Biotech UK Limited Patent: US6600028 B1, 2003 ;

~%

4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶结构式

4-(甲基硫代)-1H-吡唑并...

5418-10-0

文献:Moukha-Chafiq; Taha; Lazrek; Pannecouque; Witvrouw; De Clercq; Barascut; Imbach Nucleosides, Nucleotides and Nucleic Acids, 2001 , vol. 20, # 10-11 p. 1797 - 1810

~%

4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶结构式

4-(甲基硫代)-1H-吡唑并...

5418-10-0

文献:Robins Journal of the American Chemical Society, 1956 , vol. 78, p. 784,787 Journal of the American Chemical Society, 1957 , vol. 79, p. 6407,6413

 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶上下游产品

4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶上游产品  5

4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶下游产品  1

 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶海关

海关编码 2933990090
中文概述 2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%
申报要素 品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期
Summary 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

 4-(甲基硫代)-1H-吡唑并[3,4-d]嘧啶靶点实验

查看更多实验

实验名称:Luminescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:mu-type opioid receptor isoform MOR-1 [Homo sapiens]
External Id:OPRM1-OPRD1_AG_LUMI_1536_1X%ACT PRUN
实验名称:QFRET-based biochemical primary high throughput screening assay to identify exosite i...
来源:The Scripps Research Institute Molecular Screening Center
靶标:disintegrin and metalloproteinase domain-containing protein 17 preproprotein [Homo sapiens]
External Id:ADAM17_INH_QFRET_1536_1X%INH PRUN
实验名称:Fluorescence-based cell-based primary high throughput screening assay to identify ago...
来源:The Scripps Research Institute Molecular Screening Center
靶标:muscarinic acetylcholine receptor M1 [Homo sapiens]
External Id:CHRM1_AG_FLUO8_1536_1X%ACT PRUN
实验名称:qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in...
来源:NCGC
靶标:TDP1 protein [Homo sapiens]
External Id:TDP1100
实验名称:qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in...
来源:NCGC
靶标:TDP1 protein [Homo sapiens]
External Id:TDP1101
实验名称:Schnurri-3 Inhibitors: specific inducers of adult bone formation Measured in Cell-Bas...
来源:Broad Institute
靶标:N/A
External Id:2134-01_Inhibitor_SinglePoint_HTS_Activity_Set2
实验名称:Fluorescence polarization to screen for inhibitor that competite the binding of FadD2...
来源:Broad Institute
靶标:FATTY-ACID-CoA LIGASE FADD28 (FATTY-ACID-CoA SYNTHETASE)
External Id:2147-01_Inhibitor_SinglePoint_HTS_Activity
实验名称:Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfect...
来源:Broad Institute
靶标:N/A
External Id:Bursicon-induced LGR2 mediated cAMP production in LGR-2/CRE6x-Luciferase co-transfected HEK293 cells Inhibition - 7011-01_Antagonist_SinglePoint_HTS_Activity
实验名称:High throughput screen for small molecule inhibitors of a hypoxia-regulated fluoresce...
来源:ICCB-Longwood/NSRB Screening Facility, Harvard Medical School
靶标:N/A
External Id:HMS1149-MLP
实验名称:Inhibition Eimeria tenella growth
来源:ChEMBL
靶标:Eimeria tenella
External Id:CHEMBL674773
共95条,当前第1页,共10页
1
2
3
4
5
本网页内容来自不同专业数据源,如对内容有疑义,欢迎联系service1@chemsrc.com。